Perfil
Todd W.
Rich served as an Independent Director at Mallinckrodt Hospital Products, Inc. from 2011 to 2014.
Prior to that, he was the SVP & Head-Global Development Operations & Quality at Genentech, Inc. from 2011 to 2012.
Dr. Rich holds an MBA from Stanford University, a doctorate from Wayne State University, an undergraduate degree from Amherst College, and a graduate degree from the University of Michigan.
Antiguos cargos conocidos de Todd W. Rich.
| Empresas | Cargo | Fin |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 19/03/2014 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/09/2012 |
Formación de Todd W. Rich.
| Stanford University | Masters Business Admin |
| Wayne State University (Michigan) | Doctorate Degree |
| Amherst College | Undergraduate Degree |
| University of Michigan | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
- Bolsa de valores
- Insiders
- Todd W. Rich
